Upcoming webinar
Beyond the data: Navigating exome and genome results in general practice
Date: Thursday, September 17, 2026
Time: 12:00 PM ET | 9:00 AM PT (60-minute webinar)
Registrants will receive a recording of the webinar approximately one week after the event.
Learn more about:
Designed specifically for non-genetics clinicians, this educational webinar provides a practical roadmap for converting complex genomic testing into clear, patient-centered care.
Led by board-certified genetic counselor Tara Funari, MS, CGC, the session equips child neurologists, developmental pediatricians and other specialists to confidently navigate the full spectrum of diagnostic outcomes—from definitive variants to complex secondary findings.
Attendees will explore key decision points for escalating from targeted exome to whole genome testing, while establishing actionable strategies for ongoing case review as medical knowledge evolves.
By mastering these essentials, clinicians can bridge the gap between advanced diagnostic technology and meaningful, compassionate patient management.
Objectives:
- Define the clinical nuances of positive, uncertain and negative results.
- Differentiate between ACMG secondary findings and incidental discoveries.
- Identify clinical triggers for reflexing from exome to genome.
- Establish standard protocols for periodic data reanalysis.
Hear from our speakers:
Tara Funari, MS, CGC
Tara Funari is a board-certified genetic counselor with over two decades of experience across clinical and laboratory genomics. A graduate of UC Irvine’s Genetic Counseling Program, Tara brings a broad, multidisciplinary perspective to modern genomic medicine. Her extensive clinical background spans pediatrics, neurology, prenatal, cancer genetics, and connective tissue and skeletal disorders. In addition to her patient care, Tara has served as a study coordinator for multiple rare disease clinical trials and has co-authored several peer-reviewed publications.
In the laboratory setting, Tara specializes in the analysis, interpretation, and reporting of complex exome and genome sequencing results, effectively bridging high-throughput technology with direct patient care. She joined Natera five years ago as part of the Horizon Women’s Health team, where her expertise has been instrumental in expanding rare disease testing initiatives.
Brian Schoenfeld, MS, LCGC
Brian Schoenfeld blends a rigorous background in molecular research with a deep commitment to clinical excellence in Genetic Counseling. As a specialist in Rare Disease, Brian’s career is defined by a transition from the laboratory bench to the patient’s side—a journey that informs his comprehensive understanding of genetic pathology.
Before earning his credentials at Arcadia University, Brian dedicated nearly a decade to investigating the mechanisms of inherited neurological conditions. His research at premier institutions like the University of Pennsylvania and Albert Einstein College of Medicine resulted in a body of peer-reviewed work that remains influential in the study of Alzheimer’s and Fragile X Syndrome.
Today, Brian serves as the Director of Medical Science for Rare Disease at Natera.
Zenith™ has been developed and its performance characteristics determined by the CLIA-certified laboratory performing the test. The test has not been cleared or approved by the US Food and Drug Administration (FDA). CAP accredited, ISO 13485 certified, and CLIA certified. © 2026 Natera, Inc. All Rights Reserved.
13011 McCallen Pass, Building A Suite 100 | Austin, TX 78753 | natera.com | Do Not Share My Personal Information | Privacy Policy